Prevalence, Associated Factors, and Impact on Quality of Life of Migraine in a Community in Northeast China
- PMID: 27128478
- DOI: 10.11607/ofph.1584
Prevalence, Associated Factors, and Impact on Quality of Life of Migraine in a Community in Northeast China
Abstract
Aims: To validate the Chinese version of the Identification of Migraine screener (ID-Migraine), assess migraine prevalence, identify potential associated factors, and assess the impact of migraine on quality of life in a community in Harbin, PR China.
Methods: A community-based, cross-sectional study was conducted in the Songbei district of Harbin. After excluding the people who did not usually reside in the community, 2,588 adults were invited to participate in the study. Eligible participants underwent a physical examination before completing a questionnaire addressing demographics, medical history, and other features. Additionally, the ID-Migraine was validated by using International Classification of Headache Disorders-3 criteria, with 94 participants screening positive and 100 participants screening negative for migraine as diagnosed through a telephone interview. The diagnostic accuracy of ID-Migraine was evaluated by sensitivity and specificity, and a multivariate logistic regression model was used to determine the association between migraine and associated factors.
Results: A total of 1,143 subjects completed the questionnaire (response rate 44.2%). The prevalence of migraine was 8.9%, with a male to female prevalence ratio of 1:3.30 (3.7% versus 12.2%; P < .001). The sensitivity (90.6%; 95% confidence interval [CI] = 75.0% to 97.9%) and specificity (71.4%; 95% CI = 60.0% to 81.2%) of the ID-Migraine were satisfactory. Multivariate logistic regression analyses suggested female sex, depression, coronary heart disease (CHD), chronic obstructive pulmonary disease (COPD), ischemic stroke (IS), and hypertension were positively associated with migraine, whereas age and education level were negatively associated with migraine. Migraine was shown to significantly impact quality of life.
Conclusion: Migraine is a highly prevalent disease that can significantly affect quality of life. Age, sex, education level, depression, CHD, COPD, IS, and hypertension were all associated with migraine.
Similar articles
-
Prevalence, burden, and clinical management of migraine in China, Japan, and South Korea: a comprehensive review of the literature.J Headache Pain. 2019 Dec 5;20(1):111. doi: 10.1186/s10194-019-1062-4. J Headache Pain. 2019. PMID: 31805851 Free PMC article. Review.
-
The Prevalence and Awareness of Migraine Among University Students in Harbin, China.J Oral Facial Pain Headache. 2015 Fall;29(4):384-9. doi: 10.11607/ofph.1521. J Oral Facial Pain Headache. 2015. PMID: 26485386
-
Depression and anxiety: effect on the migraine-obesity relationship.Headache. 2007 Jun;47(6):866-75. doi: 10.1111/j.1526-4610.2007.00810.x. Headache. 2007. PMID: 17578537
-
Migrainous vertigo: prevalence and impact on quality of life.Neurology. 2006 Sep 26;67(6):1028-33. doi: 10.1212/01.wnl.0000237539.09942.06. Neurology. 2006. PMID: 17000973
-
One-year prevalence of migraine using a validated extended French version of the ID Migraine™: A Belgian population-based study.Rev Neurol (Paris). 2015 Oct;171(10):707-14. doi: 10.1016/j.neurol.2015.04.009. Epub 2015 Aug 1. Rev Neurol (Paris). 2015. PMID: 26239062 Review.
Cited by
-
Migraine treatment and healthcare costs: retrospective analysis of the China Health Insurance Research Association (CHIRA) database.J Headache Pain. 2020 May 13;21(1):53. doi: 10.1186/s10194-020-01117-2. J Headache Pain. 2020. PMID: 32404048 Free PMC article.
-
Prevalence, burden, and clinical management of migraine in China, Japan, and South Korea: a comprehensive review of the literature.J Headache Pain. 2019 Dec 5;20(1):111. doi: 10.1186/s10194-019-1062-4. J Headache Pain. 2019. PMID: 31805851 Free PMC article. Review.
-
The relationship between lung function and headache risk in middle-aged and older adults: a cross-sectional and longitudinal study.Eur J Med Res. 2025 Aug 22;30(1):790. doi: 10.1186/s40001-025-03069-2. Eur J Med Res. 2025. PMID: 40847326 Free PMC article.
-
Rimegepant orally disintegrating tablet 75 mg for acute treatment of migraine in adults from China: a subgroup analysis of a double-blind, randomized, placebo-controlled, phase 3 clinical trial.J Headache Pain. 2024 Apr 16;25(1):57. doi: 10.1186/s10194-024-01731-4. J Headache Pain. 2024. PMID: 38627638 Free PMC article. Clinical Trial.
-
Trends in migraine incidence among women of childbearing age from 1990 to 2019 and the prediction for 2030: an analysis of national data in China.J Headache Pain. 2023 Nov 27;24(1):158. doi: 10.1186/s10194-023-01692-0. J Headache Pain. 2023. PMID: 38008771 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials